The effect of GAB-D-Trp(2-Me)-D-Trp(2-Me)-LysNH(2) (EP 80661), GAB-D-Trp(2-Me)-D-Trp(2-Me)-D-Trp(2-Me)-LysNH(2) (EP 60761), GAB-D-Trp(2-Me)-LysNH(2) (EP 91071) and GAB-D-Trp(2-Mr)-D-beta Nal-Phe-LysNH(2) (EP 50885), four hexarelin peptide analogues that induce penile erection when injected into the paraventricular nucleus of the hypothalamus of male rats. on the concentration of NO2- and NO3- in the paraventricular dialysate was studied in male rats. EP peptides (1 mug) induced penile erection and increased the concentration of NO2- and NO3- in the paraventricular dialysate. In contrast, hexarelin (1 mug) was ineffective on either penile erection or paraventricular NO2- and NO3-. EP peptide-induced penile erection was prevented by the nitric oxide synthase inhibitor N-G-nitro-1-arginine methylester given into the paraventricular nucleus (20 mug). which also reduced the concomitant increase of NO2- and NO3- concentration in the paraventricular dialysate. In contrast, the oxytocin receptor antagonist [d(CH2)(5)Tyr(Me)(2)-Orn(8)]vasotocin (1 mug) given into the paraventricular nucleus, was ineffective on penile erection and on the NO2- and NO3- increase induced by EP peptides, despite its ability to prevent the sexual response induced by the above peptides when given into the lateral ventricles. The present results show that EP peptides induct penile erection by activating nitric oxide synthase in the paraventricular nucleus of the hypothalamus, possibly in the cell bodies of oxytocinergic neurons that control penile erection. (C) 2001 Elsevier Science B.V. All rights reserved.

Melis, M., Succu, S., Spano, M., Torsello, A., Locatelli, V., Muller, E., et al. (2001). Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide. EUROPEAN JOURNAL OF PHARMACOLOGY, 411(3), 305-310 [10.1016/S0014-2999(00)00929-8].

Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide

TORSELLO, ANTONIO BIAGIO;LOCATELLI, VITTORIO;
2001

Abstract

The effect of GAB-D-Trp(2-Me)-D-Trp(2-Me)-LysNH(2) (EP 80661), GAB-D-Trp(2-Me)-D-Trp(2-Me)-D-Trp(2-Me)-LysNH(2) (EP 60761), GAB-D-Trp(2-Me)-LysNH(2) (EP 91071) and GAB-D-Trp(2-Mr)-D-beta Nal-Phe-LysNH(2) (EP 50885), four hexarelin peptide analogues that induce penile erection when injected into the paraventricular nucleus of the hypothalamus of male rats. on the concentration of NO2- and NO3- in the paraventricular dialysate was studied in male rats. EP peptides (1 mug) induced penile erection and increased the concentration of NO2- and NO3- in the paraventricular dialysate. In contrast, hexarelin (1 mug) was ineffective on either penile erection or paraventricular NO2- and NO3-. EP peptide-induced penile erection was prevented by the nitric oxide synthase inhibitor N-G-nitro-1-arginine methylester given into the paraventricular nucleus (20 mug). which also reduced the concomitant increase of NO2- and NO3- concentration in the paraventricular dialysate. In contrast, the oxytocin receptor antagonist [d(CH2)(5)Tyr(Me)(2)-Orn(8)]vasotocin (1 mug) given into the paraventricular nucleus, was ineffective on penile erection and on the NO2- and NO3- increase induced by EP peptides, despite its ability to prevent the sexual response induced by the above peptides when given into the lateral ventricles. The present results show that EP peptides induct penile erection by activating nitric oxide synthase in the paraventricular nucleus of the hypothalamus, possibly in the cell bodies of oxytocinergic neurons that control penile erection. (C) 2001 Elsevier Science B.V. All rights reserved.
Articolo in rivista - Articolo scientifico
penile erection; EP 80661; EP 60761; EP 91071; EP 50885; hexarelin; oxytocin; nitric oxide (NO); paraventricular nucleus; (rat)
English
2001
411
3
305
310
none
Melis, M., Succu, S., Spano, M., Torsello, A., Locatelli, V., Muller, E., et al. (2001). Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide. EUROPEAN JOURNAL OF PHARMACOLOGY, 411(3), 305-310 [10.1016/S0014-2999(00)00929-8].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/698
Citazioni
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 18
Social impact